Tenon medical, inc. TNON.US Overview
BetaUS StockHealthcare
(No presentation for TNON)
TNON AI Analysis & Strategy
Analysis Conclusion
The stock has been awarded the top rating for its value, but its dividend score is below 2. If the company starts distributing dividends, it may yield even better investment results.
TNON Current Performance
1.14%
Tenon medical, inc.
0.98%
Avg of Sector
0.83%
S&P500
TNON Key Information
TNON Financial Forecast
Unit : USD
TNON Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | -1.01 | 89.9% | -9% | 726K | 1% | -13.6% | -400.9% |
| 2024Q3 | -2.54 | 53.3% | 0% | 3.28M | 305.6% | 263.7% | -359% |
| 2024Q2 | -3.63 | 68.9% | -14.4% | 887K | -6% | -1.6% | -424.6% |
| 2024Q1 | -8.16 | 69.1% | 655.6% | 901K | 21.3% | -1% | -497.4% |
| 2023Q4 | -10 | 70.9% | 646.3% | 719K | 66.1% | -8.2% | -387.9% |
TNON Profile
Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.